2018-2025 Microbiome Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

March 2018 | 119 pages | ID: 21CCE5F9280QEN
QYResearch

Abstracts

SUMMARY

This report studies the global Microbiome Drugs market, analyzes and researches the Microbiome Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

• Pfizer
• Second Genome
• Seres Therapeutics
• MaaT Pharma
• Enterome Bioscience
• MicroBiome Therapeutics
• Ritter Pharmaceuticals
• Rebiotix
• OpenBiome

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Probiotics
• Prebiotics
• Small Molecules
• Biological Drugs
• Other

Market segment by Application, the market can be split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

2018-2025 MICROBIOME DRUGS REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 INDUSTRY OVERVIEW OF MICROBIOME DRUGS

1.1 Microbiome Drugs Market Overview
  1.1.1 Microbiome Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Microbiome Drugs Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Microbiome Drugs Market by Type
  1.3.1 Probiotics
  1.3.2 Prebiotics
  1.3.3 Small Molecules
  1.3.4 Biological Drugs
  1.3.5 Other
1.4 Microbiome Drugs Market by End Users/Application
  1.4.1 Hospital Pharmacies
  1.4.2 Retail Pharmacies
  1.4.3 Online Pharmacies
  1.4.4 Other

2 GLOBAL MICROBIOME DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Microbiome Drugs Market Size (Value) by Players (2017 and 2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Pfizer
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Microbiome Drugs Revenue (Value) (2013-2018)
  3.1.5 Recent Developments
3.2 Second Genome
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Microbiome Drugs Revenue (Value) (2013-2018)
  3.2.5 Recent Developments
3.3 Seres Therapeutics
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Microbiome Drugs Revenue (Value) (2013-2018)
  3.3.5 Recent Developments
3.4 MaaT Pharma
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Microbiome Drugs Revenue (Value) (2013-2018)
  3.4.5 Recent Developments
3.5 Enterome Bioscience
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Microbiome Drugs Revenue (Value) (2013-2018)
  3.5.5 Recent Developments
3.6 MicroBiome Therapeutics
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Microbiome Drugs Revenue (Value) (2013-2018)
  3.6.5 Recent Developments
3.7 Ritter Pharmaceuticals
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Microbiome Drugs Revenue (Value) (2013-2018)
  3.7.5 Recent Developments
3.8 Rebiotix
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Microbiome Drugs Revenue (Value) (2013-2018)
  3.8.5 Recent Developments
3.9 OpenBiome
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Microbiome Drugs Revenue (Value) (2013-2018)
  3.9.5 Recent Developments

4 GLOBAL MICROBIOME DRUGS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Microbiome Drugs Market Size by Type (2013-2018)
4.2 Global Microbiome Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Microbiome Drugs in Future
4.4 Top Consumer/End Users of Microbiome Drugs

5 UNITED STATES MICROBIOME DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Microbiome Drugs Market Size (2013-2018)
5.2 United States Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

6 EU MICROBIOME DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Microbiome Drugs Market Size (2013-2018)
6.2 EU Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

7 JAPAN MICROBIOME DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Microbiome Drugs Market Size (2013-2018)
7.2 Japan Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

8 CHINA MICROBIOME DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Microbiome Drugs Market Size (2013-2018)
8.2 China Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

9 INDIA MICROBIOME DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Microbiome Drugs Market Size (2013-2018)
9.2 India Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

10 SOUTHEAST ASIA MICROBIOME DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Microbiome Drugs Market Size (2013-2018)
10.2 Southeast Asia Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Microbiome Drugs Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Microbiome Drugs Revenue and Growth Rate (2018-2025)
  11.1.2 EU Microbiome Drugs Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Microbiome Drugs Revenue and Growth Rate (2018-2025)
  11.1.4 China Microbiome Drugs Revenue and Growth Rate (2018-2025)
  11.1.5 India Microbiome Drugs Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Microbiome Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Microbiome Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Microbiome Drugs Market Size by Application (2018-2025)

12 MICROBIOME DRUGS MARKET DYNAMICS

12.1 Microbiome Drugs Market Opportunities
12.2 Microbiome Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Microbiome Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Microbiome Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Microbiome Drugs Product Scope
Figure Global Microbiome Drugs Market Size (Million USD) (2013-2018)
Table Global Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Global Microbiome Drugs Market Share by Regions in 2017
Figure United States Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Global Microbiome Drugs Market Share by Type in 2017
Figure Probiotics Market Size (Million USD) and Growth Rate (2013-2018)
Figure Prebiotics Market Size (Million USD) and Growth Rate (2013-2018)
Figure Small Molecules Market Size (Million USD) and Growth Rate (2013-2018)
Figure Biological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Other Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Microbiome Drugs Market Share by Application in 2017
Table Key Downstream Customer in Hospital Pharmacies
Figure Microbiome Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2013-2018)
Table Key Downstream Customer in Retail Pharmacies
Figure Microbiome Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2013-2018)
Table Key Downstream Customer in Online Pharmacies
Figure Microbiome Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2013-2018)
Table Key Downstream Customer in Other
Figure Microbiome Drugs Market Size (Million USD) and Growth Rate in Other (2013-2018)
Table Microbiome Drugs Market Size (Million USD) by Players (2017 and 2018)
Figure Microbiome Drugs Market Size Share by Players in 2017
Figure Microbiome Drugs Market Size Share by Players in 2018
Table Pfizer Basic Information List
Table Microbiome Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Microbiome Drugs Business Revenue Market Share in 2017
Table Second Genome Basic Information List
Table Microbiome Drugs Business Revenue (Million USD) of Second Genome (2013-2018)
Figure Second Genome Microbiome Drugs Business Revenue Market Share in 2017
Table Seres Therapeutics Basic Information List
Table Microbiome Drugs Business Revenue (Million USD) of Seres Therapeutics (2013-2018)
Figure Seres Therapeutics Microbiome Drugs Business Revenue Market Share in 2017
Table MaaT Pharma Basic Information List
Table Microbiome Drugs Business Revenue (Million USD) of MaaT Pharma (2013-2018)
Figure MaaT Pharma Microbiome Drugs Business Revenue Market Share in 2017
Table Enterome Bioscience Basic Information List
Table Microbiome Drugs Business Revenue (Million USD) of Enterome Bioscience (2013-2018)
Figure Enterome Bioscience Microbiome Drugs Business Revenue Market Share in 2017
Table MicroBiome Therapeutics Basic Information List
Table Microbiome Drugs Business Revenue (Million USD) of MicroBiome Therapeutics (2013-2018)
Figure MicroBiome Therapeutics Microbiome Drugs Business Revenue Market Share in 2017
Table Ritter Pharmaceuticals Basic Information List
Table Microbiome Drugs Business Revenue (Million USD) of Ritter Pharmaceuticals (2013-2018)
Figure Ritter Pharmaceuticals Microbiome Drugs Business Revenue Market Share in 2017
Table Rebiotix Basic Information List
Table Microbiome Drugs Business Revenue (Million USD) of Rebiotix (2013-2018)
Figure Rebiotix Microbiome Drugs Business Revenue Market Share in 2017
Table OpenBiome Basic Information List
Table Microbiome Drugs Business Revenue (Million USD) of OpenBiome (2013-2018)
Figure OpenBiome Microbiome Drugs Business Revenue Market Share in 2017
Table Global Microbiome Drugs Market Size (Million USD) by Type (2013-2018)
Figure Global Microbiome Drugs Market Size Share by Type in 2013
Figure Global Microbiome Drugs Market Size Share by Type in 2014
Figure Global Microbiome Drugs Market Size Share by Type in 2015
Figure Global Microbiome Drugs Market Size Share by Type in 2016
Figure Global Microbiome Drugs Market Size Share by Type in 2017
Figure Global Microbiome Drugs Market Size Share by Type in 2018
Table Global Microbiome Drugs Market Size (Million USD) by Application (2013-2018)
Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2013
Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2014
Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2015
Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2016
Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2017
Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2018
Table Top Consumer/End Users of Microbiome Drugs
Figure United States Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table United States Microbiome Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Microbiome Drugs Market Size Share by Players in 2017
Figure United States Microbiome Drugs Market Size Share by Players in 2018
Figure EU Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table EU Microbiome Drugs Market Size (Million USD) by Players (2013-2018)
Figure EU Microbiome Drugs Market Size Share by Players in 2017
Figure EU Microbiome Drugs Market Size Share by Players in 2018
Figure Japan Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Japan Microbiome Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Microbiome Drugs Market Size Share by Players in 2017
Figure Japan Microbiome Drugs Market Size Share by Players in 2018
Figure China Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table China Microbiome Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Microbiome Drugs Market Size Share by Players in 2017
Figure China Microbiome Drugs Market Size Share by Players in 2018
Figure India Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table India Microbiome Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Microbiome Drugs Market Size Share by Players in 2017
Figure India Microbiome Drugs Market Size Share by Players in 2018
Figure Southeast Asia Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Southeast Asia Microbiome Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Microbiome Drugs Market Size Share by Players in 2017
Figure Southeast Asia Microbiome Drugs Market Size Share by Players in 2018
Figure Global Microbiome Drugs Market Size (Million USD) by Regions (2018-2025)
Table Global Microbiome Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Microbiome Drugs Market Size Share by Regions in 2018
Figure Global Microbiome Drugs Market Size Share by Regions in 2025
Figure United States Microbiome Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Microbiome Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Microbiome Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Microbiome Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Microbiome Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Microbiome Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Microbiome Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Microbiome Drugs Market Size Share by Type in 2018
Figure Global Microbiome Drugs Market Size Share by Type in 2025
Table Global Microbiome Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2018
Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2025